Top suggestions for Key Note 689 Trials |
- Length
- Date
- Resolution
- Source
- Price
- Clear filters
- SafeSearch:
- Moderate
- Keynote B21
Trial Results - 942
0671B - NYU Langone
MyChart - WiMo Keynote
Medc 2006 - 859
9862371 - Keynote 689
Study Design Results - Keynote
689 - Keytruda and Melanoma
Stage 3A - Nhs960212
2023 03 01 - Simon Laban Keynote
689 - Green and Gold 2025
Movie Review - Double-Blind
Jenaveve - Perioperative Pembrolizumab
Hnscc - Marc Oliva Keynote
689 - 2nd Round of
Chemo 2020 - Keynote Arlene
Sharpe - Keynote in Bladder
Cancer - Pembrolizumab
Warnings
See more videos
More like this
